Competing interests
All authors have completed the ICMJE uniform disclosure form at
www.icmje.org/coi_disclosure.pdf and declare: grants from Jon Moulton
Charity Trust, UK Medical Research Council, Spanish Society of
Allergology and Clinical Immunology and Spanish Society of Paediatric
Allergology, Asthma and Clinical Immunology. PJT reports additional
grants from UK Medical Research Council, NIHR/Imperial BRC and UK Food
Standards Agency during the conduct of the study; personal fees from UK
Food Standards Agency, DBV Technologies, Aimmune Therapeutics,
Allergenis, and ILSI Europe, outside the submitted work. RB reports
funding from the Health Research Fund of Carlos III Health Institute
(Spain), and honoraria for lectures from LETI Pharma. MVO reports
additional research funding from the Health Research Fund of Carlos III
Health Institute (Spain), and the FPIES Foundation. PRR reports funding
from the Health Research Fund of Carlos III Health Institute, Foundation
for Biomedical Research of the Niño Jesus University Children’s
Hospital, and reports honoraria for consultancy and/or advisory board
and/or lectures from ALK-Abello, FAES Pharma, LETI Pharma, Merck,
Aimmune Therapeutics, Allergy Therapeutics, MEDA Pharma and NovartisDC.
All other authors declare no competing interests.